Pharma Natural Biotin 5000 mcg Dietary Supplement Recalled for Sub-Potency
Pharma-Natural Inc. is recalling Pharma Natural Biotin 5000 mcg dietary supplement (Lot PN10686, Exp. Date 01/24) distributed in Puerto Rico because FDA testing found the biotin content was below the detection limit.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This FDA Class III recall involves sub-potency (biotin content below detection limit). No illnesses or injuries have been reported. The hazard is a product quality deficiency rather than a direct safety threat, consistent with FDA Class III classification and standard severity criteria for such recalls.
Plain-English summary
Pharma-Natural Inc. is recalling Pharma Natural, Biotin 5000 mcg, Maximum Strength, Dietary Supplement, 30 Tablets. The affected lot is PN10686 with an expiration date of 01/24. A total of 204 bottles (102 twin packs) were distributed in Puerto Rico.
FDA sample analysis of the affected lot found that the biotin content was below the detection limit.
Consumers who purchased this product should discontinue use and may contact Pharma-Natural Inc. for additional information.
The recalled product
- Product
- Pharma Natural, Biotin 5000 mcg, Maximum Strength, Dietary Supplement, 30 Tablets
- Manufacturer
- Pharma-Natural Inc.
- Category
- Food — Dietary Supplement
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot: PN10686
- Exp. Date 01/24
Distribution
Distributed in 1 state:
Related recalls
Same manufacturer · Pharma-Natural Inc.
See all →- ModeratePharma-Natural Recalls Oliver's Harvest CBD+Capsaicin Cream for CGMP Violations
FDA (Drugs) · 2019-07-31
- ModeratePharma-Natural Recalls LidoAID Gel Due to Manufacturing Violations
FDA (Drugs) · 2019-07-31
- ModeratePharma-Natural Recalls AbeeMed Cream Due to Manufacturing Violations
FDA (Drugs) · 2019-07-31
- ModeratePharma-Natural Recalls SORBUGEN Cough Syrup Due to Manufacturing Violations
FDA (Drugs) · 2019-07-31
- ModerateLido E.R. Lidocaine Cream Recalled for Manufacturing Violations
FDA (Drugs) · 2019-07-31
Same hazard · sub potency
See all →- ModeratePovi-One Povidone-Iodine 10% Topical Drug Recall for Sub Potency
FDA (Drugs) · 2026-07-01
- HighLorazepam tablets recalled due to failed potency and impurity specifications
FDA (Drugs) · 2025-02-26
- HighLorazepam Tablets Recalled for Failed Impurity and Potency Specifications
FDA (Drugs) · 2025-02-26
- LowSinuFrin Nasal Decongestant Recalled for Sub-Potency Nationwide
FDA (Drugs) · 2024-07-03
- SeverePrescription Drug Javygtor Recalled for Sub-Potency and Powder Discoloration
FDA (Drugs) · 2024-05-15